Analysis of ALDH2 genotype in patients with hereditary breast and ovarian cancer

Analysis of ALDH2 genotype in patients with hereditary breast and ovarian cancer - ALDH2 genotyping in HBOC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030137

Enrollment

100

Registered

2017-12-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast and ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The individuals whose BRCA1/2 genetic testing gave positive results.

Exclusion criteria

Exclusion criteria: The individuals whose BRCA1/2 genetic testing gave negative results.

Design outcomes

Primary

Measure	Time frame
BRCA1/2 mutation, ADH2 genotype, age of developing cancer, clinical stage, pathological diagnosis, overall survival, progression free survival	—

Countries

Japan

Contacts

Public ContactMinoru Takata

Kyoto University Radiation Biology Center

mtakata@house.rbc.kyoto-u.ac.jp075-753-7563

Outcome results